Vice President, Biometrics, Shionogi, Inc.
Dr. Binkowitz is Vice President of Biometrics at Shionogi, Inc. after spending 32 years at Merck and Co. Dr. Binkowitz has 30 years of drug development experience and is a fellow of the ASA. Bruce is involved in the statistical community including serving on the DIA Stat Community...
Read More →
Past President, DIA Board of Directors; Professor, Shenyang Pharmaceutical University
Ling Su, PhD, is Professor and Director, Institute of Drug Regulatory Science in Shenyang Pharmaceutical University, and also a Venture Partner with Lilly Asia Ventures. Dr. Su has worked in the Bureau of Drugs of the Ministry of Health in China, and in CDER for the US FDA. His previous...
Read More →
Director, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency (PMDA)
Yoshiaki Uyama is currently Office Director, Office of Medical Informatics and Epidemiology, Pharmaceuticals & Medical Devices Agency (PMDA) of Japan. He is responsible for pharmacoepidemiological safety assessment and regulatory science research relating to new drug review and safety...
Read More →
Executive Director, Clinical Safety Statistics, BARDS, Merck Research Laboratories
Dr. William (Bill) Wang is an executive director, clinical safety statistics, Merck Research Laboratories. He has over 25 years of experience in the pharmaceutical industry, with ~18 years with Merck & Co Inc. He is co-chairing the ASA safety working group, and is a deputy topics-leader...
Read More →
